Who to call at Dr. Reddy's Laboratories, and when
Fundz watches for the moments Dr. Reddy's Laboratories starts buying, and tells you who to reach.
- An alert the day Dr. Reddy's Laboratories raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dr. Reddy's Laboratories, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dr. Reddy's Laboratories. With Fundz connected, it knows.
LaunchDr. Reddy's Laboratories launches Ivermectin Tablets USP, 3 mg, in the U.S. market.
HyderabadManufacturingBiotechnologyHealth CareTravelEmployee BenefitsPharmaceuticalInsurtechInsurancepharmaceuticalsProduct Description
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announced the launch of Ivermectin Tablets USP, 3 mg, which is a bioequivalent product to Merck's STROMECTOL® Tablets. This product represents a limited-competition offering in the generic market.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dr. Reddy's Laboratories ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Product Launch Insights
What this usually meansDr. Reddy's Laboratories shipped something new. Fundz reads product launches, trademark filings and hiring together.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.